NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Active Not RecruitingPhase 4

Sponsor: Kelley-Ross & Associates, Inc.

Conditions: HIV

Interventions: Lenacapavir long-acting, Standard of Care (SOC)

Countries: United States

This is an open-label, single center study to evaluate implementation of a pharmacist-managed delivery of L4P in a community pharmacy setting and the impact of twice-yearly vs. quarterly PrEP visits on STI rates.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* 18 years of age or older at the time of screening
* weight greater than or equal to 35kg
* HIV-negative status
* Willing to provide informed consent and undergo all required study procedures

Exclusion Criteria:

* Unknown or positive HIV status
* Coadministration of drugs that significantly decreases lenacapavir concentrations according to the FDA package insert
* Any participant that do not meet criteria for management under the CDTA

Locations (1)

Seattle, Washington, United States